These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35224365)

  • 21. Genetic and biochemical modulation of 5-fluorouracil through the overexpression of thymidine kinase: an in-vitro study.
    Fanciullino R; Evrard A; Cuq P; Giacometti S; Peillard L; Mercier C; Aubert C; Milano G; Ciccolini J
    Anticancer Drugs; 2006 Apr; 17(4):463-70. PubMed ID: 16550005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis and thymidylate synthase inductions by 5-fluorouracil in gastric cancer cells with or without p53 mutation.
    Yukimoto K; Nakata B; Muguruma K; Yashiro M; Ohira M; Ishikawa T; Hino M; Hirakawa K
    Int J Oncol; 2001 Aug; 19(2):373-8. PubMed ID: 11445854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Level of 5-fluorodeoxyuridine 5'-monophosphate in cancerous tissue in patients with gastric cancer under preoperative administration of TS-1. A preliminary study.
    Yamamoto S; Kubota K
    J Exp Clin Cancer Res; 2005 Sep; 24(3):457-62. PubMed ID: 16270533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological quantitation of thymidylate synthase-FdUMP-5,10-methylenetetrahydrofolate ternary complex with the monoclonal antibody TS 106.
    Drake JC; Allegra CJ; Johnston PG
    Anticancer Drugs; 1993 Aug; 4(4):431-5. PubMed ID: 8400344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells.
    Matsushita S; Ikeda R; Nishizawa Y; Che XF; Furukawa T; Miyadera K; Tabata S; Ushiyama M; Tajitsu Y; Yamamoto M; Takeda Y; Minami K; Mataki H; Kanzaki T; Yamada K; Kanekura T; Akiyama S
    Int J Oncol; 2010 May; 36(5):1193-200. PubMed ID: 20372793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells.
    Chen TL; Erlichman C
    Cancer Chemother Pharmacol; 1992; 30(5):370-6. PubMed ID: 1380407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A High-Resolution Mass Spectrometry-Based Quantitative Metabolomic Workflow Highlights Defects in 5-Fluorouracil Metabolism in Cancer Cells with Acquired Chemoresistance.
    Shahi S; Ang CS; Mathivanan S
    Biology (Basel); 2020 May; 9(5):. PubMed ID: 32384705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacalcitol increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating the thymidylate synthase.
    Milczarek M; Rossowska J; Klopotowska D; Stachowicz M; Kutner A; Wietrzyk J
    J Steroid Biochem Mol Biol; 2019 Jun; 190():139-151. PubMed ID: 30923017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance of colorectal cancer cells to 5-FUdR and 5-FU caused by Mycoplasma infection.
    Jetté L; Bissoon-Haqqani S; Le François B; Maroun JA; Birnboim HC
    Anticancer Res; 2008; 28(4B):2175-80. PubMed ID: 18751392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
    Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
    Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro differential metabolism and activity of 5-fluorouracil between short-term, high-dose and long-term, low-dose treatments in human squamous carcinoma cells.
    Qin B; Tanaka R; Ariyama H; Shibata Y; Arita S; Kusaba H; Baba E; Harada M; Nakano S
    Anticancer Drugs; 2006 Apr; 17(4):439-43. PubMed ID: 16550002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Fluorouracil metabolizing enzymes.
    McLeod HL; Milne LH; Johnston SJ
    Methods Mol Med; 1999; 28():111-20. PubMed ID: 21374032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells.
    Mori R; Ukai J; Tokumaru Y; Niwa Y; Futamura M
    Oncol Lett; 2022 Sep; 24(3):311. PubMed ID: 35949616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.
    Liu J; Skradis A; Kolar C; Kolath J; Anderson J; Lawson T; Talmadge J; Gmeiner WH
    Nucleosides Nucleotides; 1999 Aug; 18(8):1789-802. PubMed ID: 10478484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects.
    Gmeiner WH; Okechukwu CC
    Cancer Drug Resist; 2023; 6(2):257-272. PubMed ID: 37457133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive interaction between 5-FU and FdUMP[10] in the inhibition of human colorectal tumor cell proliferation.
    Liu J; Kolath J; Anderson J; Kolar C; Lawson TA; Talmadge J; Gmeiner WH
    Antisense Nucleic Acid Drug Dev; 1999 Oct; 9(5):481-6. PubMed ID: 10555156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
    Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts.
    Liu C; Willingham M; Liu J; Gmeiner WH
    Int J Oncol; 2002 Aug; 21(2):303-8. PubMed ID: 12118325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
    Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel chemical strategies for thymidylate synthase inhibition.
    Gmeiner WH
    Curr Med Chem; 2005; 12(2):191-202. PubMed ID: 15638735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.